AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
101 hedge funds and large institutions have $113M invested in Aegerion Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
90% less capital invested
Capital invested by funds: $1.18B → $113M (-$1.06B)
Holders
101
Holding in Top 10
1
Calls
$539K
Puts
$669K
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.85M | |
| 3 | +$1.1M | |
| 4 |
AC
Armistice Capital
New York
|
+$1.1M |
| 5 |
Goldman Sachs
New York
|
+$722K |
Top Sellers
| 1 | -$844M | |
| 2 | -$4.39M | |
| 3 | -$3.57M | |
| 4 |
AC
Amici Capital
New York
|
-$2.46M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.21M |